List of Tables
Table 1. Global Hemophilia AAV Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of AVV5 Vector
Table 3. Key Players of AAVrh74 Vector
Table 4. Global Hemophilia AAV Gene Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Hemophilia AAV Gene Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Hemophilia AAV Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Hemophilia AAV Gene Therapy Market Share by Region (2021–2026)
Table 8. Global Hemophilia AAV Gene Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Hemophilia AAV Gene Therapy Market Share by Region (2027–2032)
Table 10. Hemophilia AAV Gene Therapy Market Trends
Table 11. Hemophilia AAV Gene Therapy Market Drivers
Table 12. Hemophilia AAV Gene Therapy Market Challenges
Table 13. Hemophilia AAV Gene Therapy Market Restraints
Table 14. Global Hemophilia AAV Gene Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Hemophilia AAV Gene Therapy Market Share by Players (2021–2026)
Table 16. Global Top Hemophilia AAV Gene Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Hemophilia AAV Gene Therapy Revenue, 2025
Table 17. Ranking of Global Top Hemophilia AAV Gene Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Hemophilia AAV Gene Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Hemophilia AAV Gene Therapy, Headquarters and Area Served
Table 20. Global Key Players of Hemophilia AAV Gene Therapy, Products and Applications
Table 21. Global Key Players of Hemophilia AAV Gene Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Hemophilia AAV Gene Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Hemophilia AAV Gene Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Hemophilia AAV Gene Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Hemophilia AAV Gene Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Hemophilia AAV Gene Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Hemophilia AAV Gene Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Hemophilia AAV Gene Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Hemophilia AAV Gene Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Hemophilia AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Hemophilia AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Hemophilia AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Hemophilia AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Hemophilia AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Hemophilia AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Hemophilia AAV Gene Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Hemophilia AAV Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Hemophilia AAV Gene Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Hemophilia AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Hemophilia AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Hemophilia AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Hemophilia AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. BioMarin (Roctavian) Company Details
Table 47. BioMarin (Roctavian) Business Overview
Table 48. BioMarin (Roctavian) Hemophilia AAV Gene Therapy Product
Table 49. BioMarin (Roctavian) Revenue in Hemophilia AAV Gene Therapy Business (US$ Million), 2021–2026
Table 50. BioMarin (Roctavian) Recent Development
Table 51. CSL/uniQure (Hemgenix&Glybera) Company Details
Table 52. CSL/uniQure (Hemgenix&Glybera) Business Overview
Table 53. CSL/uniQure (Hemgenix&Glybera) Hemophilia AAV Gene Therapy Product
Table 54. CSL/uniQure (Hemgenix&Glybera) Revenue in Hemophilia AAV Gene Therapy Business (US$ Million), 2021–2026
Table 55. CSL/uniQure (Hemgenix&Glybera) Recent Development
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer Hemophilia AAV Gene Therapy Product
Table 59. Pfizer Revenue in Hemophilia AAV Gene Therapy Business (US$ Million), 2021–2026
Table 60. Pfizer Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report
List of Figures
Figure 1. Hemophilia AAV Gene Therapy Picture
Figure 2. Global Hemophilia AAV Gene Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Hemophilia AAV Gene Therapy Market Share by Type: 2025 vs 2032
Figure 4. AVV5 Vector Features
Figure 5. AAVrh74 Vector Features
Figure 6. Global Hemophilia AAV Gene Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Hemophilia AAV Gene Therapy Market Share by Application: 2025 vs 2032
Figure 8. Hemophilia A Case Studies
Figure 9. Hemophilia B Case Studies
Figure 10. Hemophilia AAV Gene Therapy Report Years Considered
Figure 11. Global Hemophilia AAV Gene Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Hemophilia AAV Gene Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Hemophilia AAV Gene Therapy Market Share by Region: 2025 vs 2032
Figure 14. Global Hemophilia AAV Gene Therapy Market Share by Players in 2025
Figure 15. Global Hemophilia AAV Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Hemophilia AAV Gene Therapy Revenue in 2025
Figure 17. North America Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Hemophilia AAV Gene Therapy Market Share by Country (2021–2032)
Figure 19. United States Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Hemophilia AAV Gene Therapy Market Share by Country (2021–2032)
Figure 23. Germany Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Hemophilia AAV Gene Therapy Market Share by Region (2021–2032)
Figure 31. China Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Hemophilia AAV Gene Therapy Market Share by Country (2021–2032)
Figure 39. Mexico Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Hemophilia AAV Gene Therapy Market Share by Country (2021–2032)
Figure 43. Israel Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Hemophilia AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. BioMarin (Roctavian) Revenue Growth Rate in Hemophilia AAV Gene Therapy Business (2021–2026)
Figure 47. CSL/uniQure (Hemgenix&Glybera) Revenue Growth Rate in Hemophilia AAV Gene Therapy Business (2021–2026)
Figure 48. Pfizer Revenue Growth Rate in Hemophilia AAV Gene Therapy Business (2021–2026)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
